Philip Shirk
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 detection and testing
-
- Vaccine Coverage and Hesitancy
Papers in
-
- Viral gastroenteritis research and epidemiology 2
- SARS-CoV-2 and COVID-19 Research 2
- SARS-CoV-2 detection and testing 1
-
- Respiratory viral infections research 1
- Co-authors
- Anastasia S. Lambrou (2 shared papers)Allison Avrich Ciesla (1 shared paper)Amadea Britton (1 shared paper)Zachary Smith (2 shared papers)Joseph D. Miller (2 shared papers)Josephine Mak (1 shared paper)Clinton R. Paden (2 shared papers)Katherine E. Fleming-Dutra (1 shared paper)
- Partner nations
- United States
In The Last Decade
Philip Shirk
2 papers receiving 88 citations
Philip Shirk's Hit Papers
Peers
Comparison fields: 5 of 19
- Infectious Diseases 73
- Health 22
- Modeling and Simulation 12
- Animal Science and Zoology 8
- Epidemiology 12
Countries citing papers authored by Philip Shirk
This map shows the geographic impact of Philip Shirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Shirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Shirk more than expected).
Fields of papers citing papers by Philip Shirk
This network shows the impact of papers produced by Philip Shirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Shirk. The network helps show where Philip Shirk may publish in the future.
Co-authors
The 18 scholars most cited alongside Philip Shirk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024 Hit paper breakdown → | 2024 | 85 |
| 2 | 2023 | 6 |
About Philip Shirk
Philip Shirk is a scholar working on Infectious Diseases, Epidemiology, Organic Chemistry, Surgery and Communication, having authored 2 papers that have together received 91 indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), SARS-CoV-2 detection and testing (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Infectious Diseases (73 citations), Health (22 citations), Modeling and Simulation (12 citations), Animal Science and Zoology (8 citations) and Epidemiology (12 citations). Philip Shirk has collaborated with scholars based in United States. Frequent co-authors include Anastasia S. Lambrou, Allison Avrich Ciesla, Amadea Britton, Zachary Smith, Joseph D. Miller, Josephine Mak, Clinton R. Paden, Katherine E. Fleming-Dutra, Ruth Link‐Gelles and Benjamin J. Silk. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.